Royalty Pharma
RPRX
#881
Rank
A$37.71 B
Marketcap
A$65.20
Share price
0.99%
Change (1 day)
26.53%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: A$37.71 Billion

As of March 2026 Royalty Pharma has a market cap of A$37.71 Billion. This makes Royalty Pharma the world's 881th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026A$37.71 B10.44%
2025A$34.14 B41.15%
2024A$24.19 B-2.14%
2023A$24.72 B-3.5%
2022A$25.61 B8.51%
2021A$23.60 B-6.55%
2020A$25.26 B

End of Day market cap according to different sources

On Mar 16th, 2026 the market cap of Royalty Pharma was reported to be:

A$37.61 Billion
by Nasdaq info icon info icon
A$37.71 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
A$270.22 B 616.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$1.252 T 3,220.05%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$2.29 B-93.92%๐Ÿ‡บ๐Ÿ‡ธ USA